bcr_patient_uuid
bcr_patient_barcode
form_completion_date
tissue_prospective_collection_indicator
tissue_retrospective_collection_indicator
days_to_birth
gender
menopause_status
race
ethnicity
other_dx
history_of_neoadjuvant_treatment
person_neoplasm_cancer_status
vital_status
days_to_last_followup
days_to_death
radiation_therapy
postoperative_rx_tx
histological_type_other
year_of_initial_pathologic_diagnosis
age_at_initial_pathologic_diagnosis
initial_pathologic_diagnosis_method
init_pathology_dx_method_other
breast_carcinoma_surgical_procedure_name
surgical_procedure_purpose_other_text
margin_status
breast_carcinoma_primary_surgical_procedure_name
breast_neoplasm_other_surgical_procedure_descriptive_text
breast_cancer_surgery_margin_status
axillary_lymph_node_stage_method_type
axillary_lymph_node_stage_other_method_descriptive_text
cytokeratin_immunohistochemistry_staining_method_micrometastasis_indicator
primary_lymph_node_presentation_assessment
lymph_node_examined_count
number_of_lymphnodes_positive_by_he
number_of_lymphnodes_positive_by_ihc
system_version
pathologic_T
pathologic_N
pathologic_M
pathologic_stage
metastatic_site_at_diagnosis
metastatic_site_at_diagnosis_other
breast_carcinoma_estrogen_receptor_status
er_level_cell_percentage_category
breast_carcinoma_immunohistochemistry_er_pos_finding_scale
immunohistochemistry_positive_cell_score
positive_finding_estrogen_receptor_other_measurement_scale_text
er_detection_method_text
breast_carcinoma_progesterone_receptor_status
progesterone_receptor_level_cell_percent_category
breast_carcinoma_immunohistochemistry_progesterone_receptor_pos_finding_scale
breast_carcinoma_immunohistochemistry_pos_cell_score
pos_finding_progesterone_receptor_other_measurement_scale_text
pgr_detection_method_text
lab_proc_her2_neu_immunohistochemistry_receptor_status
her2_erbb_pos_finding_cell_percent_category
her2_immunohistochemistry_level_result
pos_finding_her2_erbb2_other_measurement_scale_text
her2_erbb_method_calculation_method_text
lab_procedure_her2_neu_in_situ_hybrid_outcome_type
her2_neu_breast_carcinoma_copy_analysis_input_total_number
fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range
her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count
her2_neu_chromosone_17_signal_ratio_value
her2_and_centromere_17_positive_finding_other_measurement_scale_text
her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
new_tumor_event_after_initial_treatment
metastatic_breast_carcinoma_estrogen_receptor_status
metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category
metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score
pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text
metastatic_breast_carcinoma_estrogen_receptor_detection_method_text
metastatic_breast_carcinoma_progesterone_receptor_status
metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category
metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score
metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text
metastatic_breast_carcinoma_progesterone_receptor_detection_method_text
metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status
metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category
metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result
metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text
metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text
metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type
her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number
metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range
her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count
metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value
metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text
metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text
anatomic_neoplasm_subdivision
clinical_M
clinical_N
clinical_T
clinical_stage
days_to_initial_pathologic_diagnosis
days_to_patient_progression_free
days_to_tumor_progression
disease_code
extranodal_involvement
histological_type
icd_10
icd_o_3_histology
icd_o_3_site
informed_consent_verified
distant_metastasis_present_ind2
patient_id
project_code
tumor_tissue_site_other
stage_other
tissue_source_site
tumor_tissue_site
